110 related articles for article (PubMed ID: 15200480)
1. The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma.
Liu CJ; Chang KW; Chao SY; Kwan PC; Chang SM; Yen RY; Wang CY; Wong YK
J Oral Pathol Med; 2004 Jul; 33(6):327-34. PubMed ID: 15200480
[TBL] [Abstract][Full Text] [Related]
2. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract][Full Text] [Related]
3. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.
Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T
Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan.
Kuo MY; Lin CY; Hahn LJ; Cheng SJ; Chiang CP
J Oral Pathol Med; 1999 Apr; 28(4):165-9. PubMed ID: 10235369
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1, p53, mdm2, and Ki67 protein expression in preneoplastic lesions of the larynx.
Capaccio P; Carboni N; Pignataro L; Scotti A; Ottaviani F; Pruneri G
J Chemother; 1997 Apr; 9(2):113-4. PubMed ID: 9176749
[No Abstract] [Full Text] [Related]
9. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan.
Chiang CP; Huang JS; Wang JT; Liu BY; Kuo YS; Hahn LJ; Kuo MY
J Oral Pathol Med; 1999 Feb; 28(2):72-6. PubMed ID: 9950253
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan.
Yen-Ping Kuo M; Huang JS; Kok SH; Kuo YS; Chiang CP
J Oral Pathol Med; 2002 Jan; 31(1):16-22. PubMed ID: 11896818
[TBL] [Abstract][Full Text] [Related]
11. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.
Kuropkat C; Venkatesan TK; Caldarelli DD; Panje WR; Hutchinson J; Preisler HD; Coon JS; Werner JA
Auris Nasus Larynx; 2002 Apr; 29(2):165-74. PubMed ID: 11893452
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of c-Jun activation in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan.
Kuo RC; Lin CY; Kuo MY
J Formos Med Assoc; 2006 Mar; 105(3):229-34. PubMed ID: 16520839
[TBL] [Abstract][Full Text] [Related]
14. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
15. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
[TBL] [Abstract][Full Text] [Related]
16. Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations.
Dowell SP; McGoogan E; Picksley SM; el-Deiry WS; Vogelstein B; Hall PA
Cytopathology; 1996 Oct; 7(5):340-51. PubMed ID: 8911758
[TBL] [Abstract][Full Text] [Related]
17. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
[TBL] [Abstract][Full Text] [Related]
18. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer.
Mathew R; Arora S; Khanna R; Mathur M; Shukla NK; Ralhan R
Eur J Cancer; 2002 Apr; 38(6):832-41. PubMed ID: 11937319
[TBL] [Abstract][Full Text] [Related]
19. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
